Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

AL Fogel, S Hill, JMC Teng - Journal of the American Academy of …, 2015 - Elsevier
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …
被引用次数：63 相关文章

Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

AL Fogel, S Hill, JMC Teng - Journal of the American Academy of …, 2015 - infona.pl
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …

Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

AL Fogel, S Hill, JMC Teng - Journal of the American Academy of …, 2015 - jaad.org
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …

Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

AL Fogel, S Hill, JMC Teng - Journal of the American …, 2015 - pubmed.ncbi.nlm.nih.gov
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …

Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology.

AL Fogel, S Hill, JM Teng - Journal of the American Academy of …, 2015 - europepmc.org
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …